Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer

Graham Caine; AL Harris; K Christodoulos; Gregory Lip; Andrew Blann

doi:10.1016/j.canlet.2004.09.036

Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer

Graham Caine, AL Harris, K Christodoulos, Gregory Lip, Andrew Blann

Research output: Contribution to journal › Article

7 Citations (Scopus)

Abstract

The effects of combination anti-angiogenesis therapy (marimastat, captopril and fragmin) on plasma levels of coagulation initiator tissue factor (TF), platelet marker soluble P-selectin and angiogenic vascular endothelial growth factor (VEGF) were tested in 25 patients with advanced cancer. They had higher soluble P-selectin (P

Original language	English
Pages (from-to)	163-7
Number of pages	5
Journal	Cancer Letters
Volume	219
Issue number	2
DOIs	https://doi.org/10.1016/j.canlet.2004.09.036
Publication status	Published - 10 Mar 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.canlet.2004.09.036

Cite this

@article{b1b3e4c473a04dd58d31c46d62e460b7,

title = "Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer",

abstract = "The effects of combination anti-angiogenesis therapy (marimastat, captopril and fragmin) on plasma levels of coagulation initiator tissue factor (TF), platelet marker soluble P-selectin and angiogenic vascular endothelial growth factor (VEGF) were tested in 25 patients with advanced cancer. They had higher soluble P-selectin (P",

author = "Graham Caine and AL Harris and K Christodoulos and Gregory Lip and Andrew Blann",

year = "2005",

month = mar,

day = "10",

doi = "10.1016/j.canlet.2004.09.036",

language = "English",

volume = "219",

pages = "163--7",

journal = "Cancer Letters",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer

AU - Caine, Graham

AU - Harris, AL

AU - Christodoulos, K

AU - Lip, Gregory

AU - Blann, Andrew

PY - 2005/3/10

Y1 - 2005/3/10

N2 - The effects of combination anti-angiogenesis therapy (marimastat, captopril and fragmin) on plasma levels of coagulation initiator tissue factor (TF), platelet marker soluble P-selectin and angiogenic vascular endothelial growth factor (VEGF) were tested in 25 patients with advanced cancer. They had higher soluble P-selectin (P

AB - The effects of combination anti-angiogenesis therapy (marimastat, captopril and fragmin) on plasma levels of coagulation initiator tissue factor (TF), platelet marker soluble P-selectin and angiogenic vascular endothelial growth factor (VEGF) were tested in 25 patients with advanced cancer. They had higher soluble P-selectin (P

U2 - 10.1016/j.canlet.2004.09.036

DO - 10.1016/j.canlet.2004.09.036

M3 - Article

C2 - 15723715

VL - 219

SP - 163

EP - 167

JO - Cancer Letters

JF - Cancer Letters

IS - 2

ER -

Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this